Condensed Consolidated Statements of Shareholders’ Equity (Unaudited) - USD ($) shares in Thousands, $ in Millions		Total	Ordinary Shares and Additional Paid-in Capital	Retained Earnings (Accumulated Deficit)	Accumulated  Other Comprehensive Loss, Net of Tax	Non- redeemable Non- controlling Interests
Beginning balance (in shares) at Dec. 31, 2024			216,000
Beginning balance at Dec. 31, 2024		$ 6,305	$ 13,175	$ (2,309)	$ (4,745)	$ 184
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[1]	986		965		21
Shares issued - employee stock compensation plans (in shares)			700
Shares issued - employee stock compensation plans		$ (111)	$ (111)
Shares repurchased (in shares)		(600)	(600)
Shares repurchased		$ (250)		(250)
Share-based compensation expense		147	$ 147
Dividends to shareholders		(146)		(146)
Net change in fair value of financial instruments		3			3
Net foreign currency translation adjustments		239			239
Net postretirement benefit obligation		47			47
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(14)				(14)
Remeasurement of redemption value of redeemable noncontrolling interest		(11)	$ (11)
Ending balance (in shares) at Mar. 31, 2025			216,100
Ending balance at Mar. 31, 2025		$ 7,195	$ 13,200	(1,740)	(4,456)	191
Beginning balance (in shares) at Dec. 31, 2025		214,500	214,500
Beginning balance at Dec. 31, 2025		$ 9,459	$ 13,440	(245)	(3,843)	107
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	[2]	1,240		1,212		28
Shares issued - employee stock compensation plans (in shares)			600
Shares issued - employee stock compensation plans		$ (68)	$ (68)
Shares repurchased (in shares)		(1,500)	(1,500)
Shares repurchased		$ (500)		(500)
Share-based compensation expense		82	$ 82
Dividends to shareholders		(160)		(160)
Net change in fair value of financial instruments		(4)			(4)
Net foreign currency translation adjustments		(108)			(108)
Net postretirement benefit obligation		27			27
Net purchases of subsidiary shares from nonredeemable noncontrolling interests		(3)	(2)			(1)
Dividends paid to nonredeemable noncontrolling interests on subsidiary common stock		(10)				(10)
Remeasurement of redemption value of redeemable noncontrolling interest		$ 3	$ 3
Ending balance (in shares) at Mar. 31, 2026		213,600	213,600
Ending balance at Mar. 31, 2026		$ 9,958	$ 13,455	$ 307	$ (3,928)	$ 124

[1] The Company’s Net income totaled $982 million for the quarter ended March 31, 2025, which included $4 million of Net loss related to redeemable noncontrolling interests.

[2] The Company’s Net income totaled $1.2 billion for the quarter ended March 31, 2026, which included $1 million of Net loss related to redeemable noncontrolling interests.